enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ranitidine - Wikipedia

   en.wikipedia.org/wiki/Ranitidine

   Ranitidine, previously sold under the brand name Zantac [a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12] It can be given by mouth, injection into a muscle, or injection into a vein.

3. Zantac settlements - Wikipedia

   en.wikipedia.org/wiki/Zantac_settlements

   Ranitidine, a heartburn medicine sold under the brand name Zantac among others, was pulled from shelves in 2019, [1] following disclosure [2] of potential carcinogenic effects, [3] [4] which its manufacturers were accused of "engaging in a decades-long scheme to conceal." [5]

4. Canada v GlaxoSmithKline Inc - Wikipedia

   en.wikipedia.org/wiki/Canada_v_GlaxoSmithKline_Inc

   Molecular structure of ranitidine. In 1976, a predecessor of GlaxoSmithKline Inc. ("GSK") discovered the drug ranitidine, which was approved for sale in Canada in 1981 and marketed as Zantac. Ranitidine's primary manufacture was conducted by related companies located in the United Kingdom and Singapore, and it was subsequently sold to Adechsa ...

5. GSK whistleblower claims drugmaker cheated US government over ...

   www.aol.com/news/gsk-faces-whistleblower-lawsuit...

   Zantac became the world's best selling medicine in 1988, and was one of the first drugs to top $1 billion in annual sales. The FDA asked drugmakers in April 2020 to pull Zantac and generic ...

6. Sanofi to settle 4,000 lawsuits claiming Zantac is linked to ...

   www.aol.com/sanofi-settle-4-000-lawsuits...

   Sanofi discontinued the ranitidine formulation of Zantac, and the new formulation, Zantac 360, is made with a different active ingredient.

7. GSK settles two California lawsuits related to heartburn drug ...

   www.aol.com/news/gsk-settles-two-california...

   Former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim are facing about 4,000 claims in California state court and about 2,000 in various other state courts around the country.